Evaluation of prothrombin complex concentrate, recombinant activated factor VII and fibrinogen concentrate to reverse apixaban in a rabbit model

被引：0
|
作者：
Martin, A-C. [1 ]
Le Bonniec, B. [2 ]
Lecompte, T. [3 ]
Dizier, B. [2 ]
Emmerich, J. [2 ]
Fischer, A-M. [4 ]
Samama, C-M. [5 ]
Godier, A. [5 ]
机构：
[1] Mil Hosp HIA Val de Grace, Paris, France
[2] Paris Descartes Univ, Inserm U765, Paris, France
[3] Univ Hosp Nancy, Nancy, France
[4] Hop Europeen Georges Pompidou, AP HP, Paris, France
[5] Hosp Hotel Dieu, AP HP, Paris, France
来源：
CARDIOVASCULAR RESEARCH | 2012年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [41] Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery
    Harper, Patrick C.
    Smith, Mark M.
    Brinkman, Nathan J.
    Passe, Melissa A.
    Schroeder, Darrell R.
    Said, Sameh M.
    Nuttall, Gregory A.
    Oliver, William C.
    Barbara, David W.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2018, 32 (01) : 151 - 157
  • [42] Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist Reversal
    Rowe, A. Shaun
    Dietrich, Scott K.
    Phillips, John W.
    Foster, Kaci E.
    Canter, Joshua R.
    CRITICAL CARE MEDICINE, 2018, 46 (06) : 943 - 948
  • [43] Comparison of Prothrombin Complex Concentrate with Activated Factor VII Use for Bleeding Following Cardiopulmonary Bypass in Children
    Benson, John W. W.
    Hraska, Viktor
    Scott, John P. P.
    Stuth, Eckehard A. E.
    Yan, Ke
    Zhang, Jian
    Niebler, Robert A. A.
    WORLD JOURNAL FOR PEDIATRIC AND CONGENITAL HEART SURGERY, 2023, 14 (03) : 282 - 288
  • [44] Reversal of rivaroxaban-induced prolongation of clotting time with prothrombin complex concentrate (PCC), activated prothrombin complex concentrate (aPCC) and recombinant Factor VIIa (rFVIIa) in vitro
    Perzborn, Elizabeth
    Heitmeier, Stefan
    Laux, Volker
    THROMBOSIS RESEARCH, 2012, 130 : S113 - S114
  • [45] Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model
    Mitterlechner, T.
    Innerhofer, P.
    Streif, W.
    Loedl, M.
    Danninger, T.
    Klima, G.
    Hansson, K.
    Fries, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (04) : 729 - 737
  • [46] Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery
    Bowman, Lyndsey J.
    Uber, Walter E.
    Stroud, Martha R.
    Christiansen, Lydia R.
    Lazarchick, John
    Crumbley, Arthur J., III
    Kratz, John M.
    Toole, John M.
    Crawford, Fred A., Jr.
    Ikonomidis, John S.
    ANNALS OF THORACIC SURGERY, 2008, 85 (05): : 1669 - 1677
  • [47] Economic comparison of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate using the hemophilia registries of the Czech Republic
    Salaj, P.
    Penka, M.
    Smejkal, P.
    Geierova, V.
    Ovesna, P.
    Dusek, L.
    HAEMOPHILIA, 2010, 16 : 59 - 59
  • [48] Discussion of "Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa"
    Van Dusen, Rachel
    AMERICAN JOURNAL OF SURGERY, 2018, 215 (05): : 780 - 781
  • [49] Four-factor prothrombin complex concentrate (Beriplex® P/N) mediated reversal of apixaban-induced bleeding in a rabbit model
    E Herzog
    F Kaspereit
    W Krege
    J Mueller-Cohrs
    B Doerr
    P Niebl
    G Dickneite
    Critical Care, 19 (Suppl 1):
  • [50] Fibrinogen and prothrombin complex concentrate for the management of massive bleeding
    Innerhofer, Petra
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 : S16 - S17
12345